Company Overview
FOGHORN THERAPEUTICS INC.
FHTXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
31M
2025 FY
Net Income
-74M
2025 FY
Shares Outstanding
63M
2025 FY
EPS
-1.18USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1822462
Exchange
Nasdaq
Location
US